Viral Cover-Up: SARS-CoV-2 Cap Offers New Target for Antivirals

Howard Hughes Medical Institute (HHMI) Investigator Vincent Tagliabracci and his team has delineated key steps by which SARS-CoV-2 disguises one end of its genome. Blocking this process could lead to new treatments of COVID-19.

Related Keywords

Adam Osinski ,Vincent Tagliabracci ,Warner Greene ,Patrick Eyers ,University Of Texas Southwestern Medical Center ,Howard Hughes Medical Institute Investigator ,University Of Liverpool ,Texas Southwestern Medical ,Gina Park ,Gladstone Institutes ,Howard Hughes Medical Institute ,Ohmi ,Hhmi Investigator ,Coronavirus ,Covid 19 ,Delta ,Micron ,Ars Cov 2 ,Ana Cap ,Na Genome ,Remdesivir ,Olnupiravir ,Nirmatrelvir ,Combination Therapy ,Combo Therapy ,Rna ,Inase ,Iran ,Nina Park ,Antivirals ,Iochemistry ,Structural Biology ,